Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...
Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...
DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...
Morning Overview on MSN
The FDA cleared the first over-the-counter glucose monitor made for children
Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The Food and Drug Administration cleared Dexcom’s Stelo Glucose Biosensor ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
Compare the Apple Watch, Samsung Galaxy Watch, and Pixel Watch for blood sugar tracking, CGM alerts, health trends, battery ...
Tandem’s much-awaited Mobi automated insulin delivery system is available in the U.S. The Tandem Mobi is the world’s smallest insulin delivery system to be fully controllable by a smartphone. Now with ...
Michelle Tarver, director of the FDA’s Center for Devices and Radiological Health, said in the announcement that the clearance reflects the agency’s commitment to fostering innovation for pediatric ...
The global CGM market is projected to reach a valuation of $15.69bn in 2035, as per GlobalData analysis. Credit: Around the World Photos / Shutterstock.com The US Food and Drug Administration (FDA) ...
June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom (DXCM.O), opens new tab glucose sensors it bought from licensed distributors had been slated for destruction, after ...
Add Yahoo as a preferred source to see more of our stories on Google. June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom glucose sensors it bought from licensed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results